Semaglutide Buy Research Grade — Japan

Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.

Aarise Healthcare exports Semaglutide (CAS: 910463-68-6) to research institutions in Japan. Our WHO-GMP certified facility in India supplies 98%+ purity Semaglutide for GLP-1 receptor agonism and metabolic research.

Semaglutide Export Specifications for Japan

Compound	Semaglutide
CAS Number	910463-68-6
Purity	98%+ (HPLC verified)
Form	Lyophilised powder
Regulatory Reference	PMDA
Shipping	DHL/FedEx temperature-controlled
Transit to Japan	5-10 business days
Documentation	CoA, HPLC, MS, export docs

Research Applications of Semaglutide

Semaglutide is used in GLP-1 receptor agonism and metabolic research. Research institutions in Japan source this compound for preclinical studies under applicable PMDA research regulations.

Why Japan Researchers Source Semaglutide from India

• WHO-GMP certified Indian manufacturer — internationally recognised compliance
• Competitive pricing for bulk research quantities
• Full export documentation package for PMDA compliance
• Temperature-controlled DHL/FedEx shipping to Japan
• Dedicated international research supply team
• 98%+ purity guaranteed with independent third-party CoA

Related Peptides in Japan

Tirzepatide in Japan | Retatrutide in Japan | Liraglutide in Japan | Mazdutide in Japan

Semaglutide — Other Countries

Semaglutide in USA | Semaglutide in UK | Semaglutide in Germany | Semaglutide in Australia

Source from India — Key Manufacturing Cities

Semaglutide in Mumbai, India | Semaglutide in Delhi, India | Semaglutide in Hyderabad, India | Semaglutide in Bangalore, India

Request Semaglutide for your Japan research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.